Cargando…

INR Goal Attainment and Oral Anticoagulation Knowledge of Patients Enrolled in an Anticoagulation Clinic in a Veterans Affairs Medical Center

BACKGROUND: In January 2009, the Joint Commission implemented a National Patient Safety Goal (NPSG) for ambulatory care, NPSG 3E, intended to reduce harm associated with the use of anticoagulation therapy. The 2011 NPSG 3E encompasses 8 elements of performance, including requirements that each organ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ryals, Casey A., Pierce, Kristi L., Baker, Jennifer W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438327/ https://www.ncbi.nlm.nih.gov/pubmed/21348546 http://dx.doi.org/10.18553/jmcp.2011.17.2.133

Ejemplares similares

Differences in the INR evaluation of two different thromboplastins in patients with positivity to lupus anticoagulant in ongoing oral anticoagulation
por: Ferrazzi, Paola, et al.
Publicado: (2010)

Effects of oral anticoagulation with various INR levels in deep vein thrombosis cases
por: Yetkin, Ufuk, et al.
Publicado: (2004)

Choosing Veterans Affairs: Determinants of post-9/11 Veterans’ enrollment in Veterans Affairs health care
por: Vanneman, Megan E., et al.
Publicado: (2023)

Extending INR testing intervals in warfarin patients at a multi-center anticoagulation clinic
por: Papala, Michelle, et al.
Publicado: (2021)

Overview of Efforts to Increase Women Enrollment in the Veterans Affairs Million Veteran Program
por: Whitbourne, Stacey B., et al.
Publicado: (2023)

A review of the clinical utility of INR to monitor and guide administration of prothrombin complex concentrate to orally anticoagulated patients
por: Sølbeck, Sacha, et al.
Publicado: (2012)

Veterans Perceptions of Satisfaction and Convenience with Anticoagulants for Atrial Fibrillation: Warfarin versus Direct Oral Anticoagulants
por: Mull, Hillary J, et al.
Publicado: (2020)

TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT)
por: Smith, Danielle E, et al.
Publicado: (2010)

Analysis of Factors That Interrupt With INR Control in the First Anticoagulation Clinic Monitoring Jordanian Patients
por: Al-Momany, Nairooz H., et al.
Publicado: (2019)

Elevated INR in a COVID-19 patient after concomitant administration of azvudine and anticoagulants
por: Zhang, Xi, et al.
Publicado: (2023)

Warfarin Time in Therapeutic INR Range and Direct Oral Anticoagulant Adherence for Venous Thromboembolism Across the Spectrum of Weight and Body Mass Index: Findings from Veterans Health Administration
por: Din, Natasha, et al.
Publicado: (2023)

Analysis of Initiating Anticoagulant Therapy for Atrial Fibrillation Among Persons Experiencing Homelessness in the Veterans Affairs Health System
por: Wilson, David A., et al.
Publicado: (2022)

Superior safety of direct oral anticoagulants compared to Warfarin in patients with atrial fibrillation and underlying cancer: a national veterans affairs database study
por: Sawant, Abhishek C, et al.
Publicado: (2019)

Pharmacy Technician Management of Stable, In-Range INRs Within a Clinical Pharmacy Anticoagulation Service
por: Hawkins, Kelsey L., et al.
Publicado: (2018)

Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics
por: Arbring, Kerstin, et al.
Publicado: (2013)

Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021)

Out‐of‐range INR results lead to increased health‐care utilization in four large anticoagulation clinics
por: Barnes, Geoffrey D, et al.
Publicado: (2018)

Midlife mortality in White non-Hispanic male veterans enrolled in Department of Veterans Affairs primary care, 2003–2014
por: Liu, Chuan-Fen, et al.
Publicado: (2020)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration
por: Rose, Adam J., et al.
Publicado: (2021)

Outcomes of Veterans Treated in Veterans Affairs Hospitals vs Non–Veterans Affairs Hospitals
por: Yoon, Jean, et al.
Publicado: (2023)

Recommended Therapeutic INR Range for Patients with Antiphospholipid Syndrome on Warfarin Anticoagulation: Is Moderate-Intensity (INR 2.0 - 3.0) or High-Intensity (INR 3.1 - 4.0) Better for Reducing Risk of Recurrent Thromboembolic Events?
por: Kim, Esther, et al.
Publicado: (2016)

Development and Validation of an Oral Anticoagulation Knowledge Tool (AKT)
por: Obamiro, Kehinde O., et al.
Publicado: (2016)

Assessing the knowledge of medical undergraduates on oral anticoagulation therapy
por: Sarkar, Chayna, et al.
Publicado: (2023)

The Role of Anticoagulation Clinics in the Era of New Oral Anticoagulants
por: Testa, Sophie, et al.
Publicado: (2012)

Relationship between the Occurrence of Thromboembolism and INR Measurement Interval in Low Intensity Anticoagulation after Aortic Mechanical Valve Replacement
por: Rhie, Sangho, et al.
Publicado: (2011)

Impact of INR monitoring, reversal agent use, heparin bridging, and anticoagulant interruption on rebleeding and thromboembolism in acute gastrointestinal bleeding
por: Nagata, Naoyoshi, et al.
Publicado: (2017)

Comparison of the effects of different treatment protocols on mortality in patients presenting with an INR≥10 due to warfarin-associated over-anticoagulation
por: İslam, Mehmet Muzaffer, et al.
Publicado: (2023)

The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study
por: Gemmati, Donato, et al.
Publicado: (2016)

Target-Specific Oral Anticoagulants—New Approaches in the Field of Oral Anticoagulation
por: Mani, Helen, et al.
Publicado: (2015)

New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)

Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020)

Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)

Clinical Characteristics, Comorbidities, and Response to Treatment of Veterans With Obstructive Sleep Apnea, Cincinnati Veterans Affairs Medical Center, 2005-2007
por: Samson, Pamela, et al.
Publicado: (2012)

DOAC‐Stop in lupus anticoagulant testing: Direct oral anticoagulant interference removed in most samples
por: Baker, Steven Andrew, et al.
Publicado: (2021)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Associations between illness beliefs, medication beliefs, anticoagulation‐related quality of life, and INR control: Insights from the Switching Study
por: Bartoli‐Abdou, John K., et al.
Publicado: (2018)

Performance of the LumiraDx Platform INR Test in an Anticoagulation Clinic Point-of-Care Setting Compared With an Established Laboratory Reference Method
por: Tait, Robert Campbell, et al.
Publicado: (2019)

Knowledge and medication adherence of oral anticoagulant-taking patients in Vietnam
por: Tran, Minh-Hoang, et al.
Publicado: (2023)

Manhattan Veterans Affairs Medical Center Diabetes Prevention Clinic
por: Dorcely, Brenda, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gr6avhue8fba772i7ab6v6k3bt